Approval · Notice of Compliance 32874 · 2024
CALDOLOR: Notice of Compliance 32874
Issued March 14, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32874
- Date
- March 14, 2024
- Company
- Cumberland Pharmaceuticals IncNashville, Tennessee, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph (PM) as per Advisement Letter.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CALDOLOR | Not yet assigned | — |
Medicinal ingredients
- IBUPROFEN 100 MG per ML